Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
2011

ADMA Levels and Mortality in Sepsis

Sample size: 67 publication Evidence: moderate

Author Information

Author(s): Davis Joshua S., Darcy Christabelle J., Yeo Tsin W., Jones Catherine, McNeil Yvette R., Stephens Dianne P., Celermajer David S., Anstey Nicholas M.

Primary Institution: Menzies School of Health Research and Charles Darwin University

Hypothesis

Plasma L-arginine: ADMA ratio would be decreased in sepsis, in proportion to disease severity, and would correlate with reactive hyperaemia peripheral arterial tonometry (RH-PAT) index.

Conclusion

Increased plasma ADMA is associated with higher mortality in sepsis patients.

Supporting Evidence

  • Baseline plasma L-arginine: ADMA ratio was significantly lower in sepsis patients than in controls.
  • Baseline plasma ADMA was independently associated with 28-day mortality.
  • Increase in ADMA over time correlated with increase in organ failure.

Takeaway

This study found that higher levels of a substance called ADMA in the blood can predict if someone with sepsis might not survive.

Methodology

A prospective longitudinal study measuring plasma ADMA and L-arginine concentrations in sepsis patients and controls.

Limitations

Not all sepsis patients were followed up on day 2-4 due to hospital discharge, which may underestimate improvement in microvascular and organ function.

Participant Demographics

67 patients with acute sepsis and 31 controls, well-matched in age and sex.

Statistical Information

P-Value

p<0.0001

Confidence Interval

[2.2–195.0]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017260

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication